Meeting
2014 ASCO Annual Meeting
Cancer genomics-based approach for development of new immunotherapeutics for lung cancers.
Authors
Yataro Daigo
Institute of Medical Science, University of Tokyo, Tokyo, Japan
Yataro Daigo , Atsushi Takano , Koji Teramoto , Yusuke Nakamura
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Immunotherapy
Track
Developmental Therapeutics
Sub Track
Biomarkers and Correlative Studies from Immunotherapy Trials
Clinical Trial Registration Number
NCT01069575
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3036)
DOI
10.1200/jco.2014.32.15_suppl.3036
Abstract #
3036
Poster Bd #
103
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Systematic approach for development of new immunotherapeutics for lung cancers through cancer genomics analysis.
First Author: Yataro Daigo
Poster
2014 ASCO Annual Meeting
Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients with induced immune responses and a prolonged OS.
First Author: Yoshihiro Yoshitake
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Immunologic efficacy of E39 & E39' vaccination in a phase I/IIa trial in ovarian and endometrial cancer patients.
First Author: Tommy A Brown
Poster
2022 ASCO Annual Meeting
EO2401, a novel microbiome-derived therapeutic vaccine for patients with adrenocortical carcinoma (ACC): Preliminary results of the SPENCER study.
First Author: Eric Baudin